Kodiak Sciences Inc.
KOD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001468748
In the last 90 days, Kodiak Sciences Inc. insiders filed 3 open-market purchases and 0 sales; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Kodiak Sciences Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- −6 vs. Q2 2024
- Shares held
- 39.4M
- +3.21M (+8.9%) vs. Q2 2024
- Total value
- $103.0M
- +$17.9M (+21.0%) vs. Q2 2024
- New holders
- 12
- 26 more added
- Sold out
- 18
- 29 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KOD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 200 | $2.36B |
| Q1 2026 | 188 | $2.21B |
| Q4 2025 | 158 | $1.61B |
| Q3 2025 | 121 | $727.8M |
| Q2 2025 | 101 | $155.7M |
| Q1 2025 | 107 | $120.3M |
| Q4 2024 | 108 | $418.7M |
| Q3 2024 | 98 | $103.0M |
| Q2 2024 | 106 | $94.3M |
| Q1 2024 | 114 | $228.0M |
| Q4 2023 | 96 | $124.7M |
| Q3 2023 | 101 | $76.5M |
| Q2 2023 | 128 | $293.6M |
| Q1 2023 | 127 | $254.8M |
| Q4 2022 | 136 | $298.2M |
| Q3 2022 | 143 | $324.6M |
| Q2 2022 | 131 | $313.1M |
| Q1 2022 | 142 | $330.5M |
| Q4 2021 | 153 | $3.82B |
| Q3 2021 | 153 | $4.37B |
| Q2 2021 | 149 | $4.18B |
| Q1 2021 | 167 | $5.02B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Kodiak Sciences Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −31,922−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −28,148−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,098−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −19,400−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −15,015−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −11,695−100.0% | Sold out |
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −10,351−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −10,171−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,037−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −9,046−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −7,108−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,338−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |